SONN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Sonnet Biotherapeutics Holdings Inc

NASDAQ | SONN

4.30

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$29.90M

Market Cap

-

P/E Ratio

-6.82

EPS

$10.38

52 Week High

$1.08

52 Week Low

HEALTHCARE

Sector

SONN Chart

Recent Chart
Price Action

SONN Technicals

Tags:

SONN Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $19K
Total Revenue $19K
Cost Of Revenue $83K
Costof Goods And Services Sold $83K
Operating Income -$12M
Selling General And Administrative $6.1M
Research And Development $5.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $83K
Income Before Tax -$7.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.4M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$12M
Net Income -$7.4M

Revenue & Profitability

Earnings Performance

SONN Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $2.8M
Total Current Assets $2.1M
Cash And Cash Equivalents At Carrying Value $149K
Cash And Short Term Investments $149K
Inventory -
Current Net Receivables $762K
Total Non Current Assets $653K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $3.3M
Total Current Liabilities $3.2M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $169K
Total Non Current Liabilities $47K
Capital Lease Obligations $131K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $131K
Other Current Liabilities $858K
Other Non Current Liabilities -
Total Shareholder Equity -$486K
Treasury Stock -
Retained Earnings -$118M
Common Stock $65
Common Stock Shares Outstanding $655K

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$8.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $83K
Capital Expenditures $3
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$12K
Cashflow From Financing $6.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$7.4M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $19K
Total Revenue $19K
Cost Of Revenue $83K
Costof Goods And Services Sold $83K
Operating Income -$12M
Selling General And Administrative $6.1M
Research And Development $5.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $83K
Income Before Tax -$7.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.4M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$12M
Net Income -$7.4M

SONN News

SONN Profile

Sonnet Biotherapeutics Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Sonnet Biotherapeutics Holdings Inc. is a cutting-edge biotechnology company headquartered in Princeton, New Jersey, specializing in the development of novel oncological therapies through its proprietary platform for single-acting and bispecific biologics. By harnessing advanced technology, Sonnet is committed to creating targeted treatments that effectively address significant unmet medical needs in cancer care. With a strategic focus on next-generation biologics, the company is poised to lead transformative changes in treatment paradigms, ultimately enhancing patient outcomes in oncology.

VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.